Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

@inproceedings{Chan2012IntraperitonealCI,
  title={Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy},
  author={Daniel L Chan and David L Morris and Archana Rao and Terence C Chua},
  booktitle={Cancer management and research},
  year={2012}
}
PURPOSE TO REVIEW THE TWO MAIN APPROACHES OF INTRAPERITONEAL (IP) CHEMOTHERAPY DELIVERY IN OVARIAN CANCER: postoperative adjuvant IP chemotherapy after cytoreductive surgery (CRS) and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC). METHODS A literature search was conducted to identify studies that employed postoperative adjuvant IP chemotherapy after CRS or combined CRS and intraoperative HIPEC in patients with ovarian cancer. Data of interest included chemotherapy protocol… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 59 references

A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C

  • K Votanopoulous, C Ihemelandu, P Shen, J Stewart, G Russell, EA. Levine
  • J Surg Res. Epub March 10,
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…